These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21504792)

  • 21. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone.
    Kivity S; Lerman P; Ariel R; Danziger Y; Mimouni M; Shinnar S
    Epilepsia; 2004 Mar; 45(3):255-62. PubMed ID: 15009227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential effect of ganaxolone in an animal model of infantile spasms.
    Yum MS; Lee M; Ko TS; Velíšek L
    Epilepsy Res; 2014 Nov; 108(9):1492-500. PubMed ID: 25219352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACTON PROLONGATUM® suppresses spasms head to head with Acthar® Gel in the model of infantile spasms.
    Chern CR; Chern CJ; Velíšková J; Velíšek L
    Epilepsy Behav; 2020 Apr; 105():106950. PubMed ID: 32092460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile spasms.
    Zupanc ML
    Expert Opin Pharmacother; 2003 Nov; 4(11):2039-48. PubMed ID: 14596657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical Screening for Treatments for Infantile Spasms in the Multiple Hit Rat Model of Infantile Spasms: An Update.
    Galanopoulou AS; Mowrey WB; Liu W; Li Q; Shandra O; Moshé SL
    Neurochem Res; 2017 Jul; 42(7):1949-1961. PubMed ID: 28462453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic mechanisms of catastrophic epilepsy -- overview from animal models.
    Galanopoulou AS
    Brain Dev; 2013 Sep; 35(8):748-56. PubMed ID: 23312951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Go CY; Mackay MT; Weiss SK; Stephens D; Adams-Webber T; Ashwal S; Snead OC; ;
    Neurology; 2012 Jun; 78(24):1974-80. PubMed ID: 22689735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis.
    Wan L; Yang G; Sun Y; Li Z; Zhang S; Shi X; Wang J
    Neurosci Lett; 2021 Mar; 748():135713. PubMed ID: 33571576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of ACTH in symptomatic infantile spasms with hypsarrhythmia.
    Sher PK; Sheikh MR
    Pediatr Neurol; 1993; 9(6):451-6. PubMed ID: 7605553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estradiol does not affect spasms in the betamethasone-NMDA rat model of infantile spasms.
    Chachua T; Di Grazia P; Chern CR; Johnkutty M; Hellman B; Lau HA; Shakil F; Daniel M; Goletiani C; Velíšková J; Velíšek L
    Epilepsia; 2016 Aug; 57(8):1326-36. PubMed ID: 27328917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.
    Galanopoulou AS; Gorter JA; Cepeda C
    Epilepsia; 2012 Jul; 53(7):1119-30. PubMed ID: 22578218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infantile spasms: therapy and outcome.
    Riikonen R
    J Child Neurol; 2004 Jun; 19(6):401-4. PubMed ID: 15446386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of infantile spasms.
    Hancock E; Osborne J; Milner P
    Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.
    Chiron C; Dumas C; Jambaqué I; Mumford J; Dulac O
    Epilepsy Res; 1997 Jan; 26(2):389-95. PubMed ID: 9095401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.
    Galanopoulou AS; Moshé SL
    Neurobiol Dis; 2015 Jul; 79():135-49. PubMed ID: 25968935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infantile Spasms: Outcome in Clinical Studies.
    Riikonen R
    Pediatr Neurol; 2020 Jul; 108():54-64. PubMed ID: 32305143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.